|
MGC16142 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.2571994514401E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.43800000018679E-07 |
| Normal-vs-Stage2 |
1.440940E-04 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
1.854430E-02 |
| Stage1-vs-Stage2 |
4.403400E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
8.740000E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
7.011400E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.49530002111231E-09 |
| Normal-vs-AfricanAmerican |
2.687400E-01 |
| Normal-vs-Asian |
2.027100E-04 |
| Caucasian-vs-AfricanAmerican |
5.610100E-02 |
| Caucasian-vs-Asian |
8.372000E-01 |
| AfricanAmerican-vs-Asian |
2.491000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.96919999999801E-05 |
| Normal-vs-Female |
1.1887999995519E-07 |
| Male-vs-Female |
1.122360E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.34160000000583E-05 |
| Normal-vs-Extreme_Weight |
3.56070000000486E-05 |
| Normal-vs-Obese |
3.569600E-04 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
3.930000E-01 |
| Normal_Weight-vs-Obese |
3.814000E-02 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
2.579000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.30830000000193E-05 |
| Normal-vs-Age(41-60Yrs) |
1.954510E-04 |
| Normal-vs-Age(61-80Yrs) |
3.1214999995921E-07 |
| Normal-vs-Age(81-100Yrs) |
3.216400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.375600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.798400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.386400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.617800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.652200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.202000E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
4.873400E-01 |
| Normal-vs-Grade 3 |
1.059000E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
1.137600E-01 |
| Grade 2-vs-Grade 4 |
4.873400E-01 |
| Grade 3-vs-Grade 4 |
1.059000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.29279997818088E-09 |
| Normal-vs-N1 |
5.375900E-02 |
| N0-vs-N1 |
8.067800E-01 |
|
|
